Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SYK
HoldFallen FavouriteStryker Corporation · Healthcare · United States · $126.8B · Avg Vol: $657M/d
COMPANY DESCRIPTION
Stryker Corporation is a global medical technology leader offering a diverse portfolio of orthopedic implants, medical and surgical equipment, and neurotechnology and spine products used in hospitals worldwide. The company maintains its robust market position through continuous innovation, strong relationships with medical professionals, and a broad product offering that caters to various surgical specialties, creating significant switching costs for healthcare providers.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.4B | 20.5B | 22.6B | 25.1B | 10.8% | 25.8B | 27.3B | 29.7B | 8.7% |
| EPS | 6.23 | 8.34 | 7.86 | 8.49 | 10.9% | 9.64 | 9.35 | 10.44 | 10.9% |
| Shares | 378.7M | 380.1M | 381.4M | 382.5M | +1.0% | 383.6M | — | — | — |
| Debt | 13.0B | 13.0B | 13.6B | 15.9B | 6.7% | 15.4B | — | — | — |
| Equity | 16.6B | 18.6B | 20.6B | 22.4B | 10.5% | — | — | — | — |
| Op CF | 2.6B | 3.7B | 4.2B | 5.0B | 24.3% | 5.5B | — | — | — |
| Inv CF | -2.9B | -962.0M | -3.0B | -4.9B | — | — | — | — | — |
| Fin CF | -749.0M | -1.6B | -525.0M | 113.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SYK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SYK | Stryker Corporation(you) | $126.8B | 57 | Hold |
| ABT | Abbott Laboratories | $194.6B | 61 | Hold |
| BSX | Boston Scientific Corporation | $67.9B | 48 | Hold |
| SHL.DE | Siemens Healthineers AG | $51.3B | 62 | Hold |
| EW | Edwards Lifesciences Corporation | $52.0B | 64 | Hold |
| MDT | Medtronic plc | $116.8B | 82 | Strong Buy |
| GEHC | GE HealthCare Technologies Inc. | $32.4B | 63 | Hold |
| 300760.SZ | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | $29.6B | 63 | Hold |
| DXCM | DexCom, Inc. | $34.3B | 83 | Strong Buy |
| PEN | Penumbra, Inc. | $12.7B | 51 | Hold |
Peer medians: ROE 2.9% · P/E 24.4x · Gross margin 52.6%